CN Patent

CN110974954B — 一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法

Assigned to Zhuhai Lifanda Biotechnology Co ltd · Expires 2021-03-16 · 5y expired

What this patent protects

本发明提供了一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法，涉及药物载体技术领域。该核酸疫苗按照摩尔百分比计包括25～75％可质子化阳离子脂质、5～20％阴离子脂质、0～50％结构脂质和1～5％表面活性剂。具有对核酸的包封率高，粒径分布较窄的优点。

USPTO Abstract

本发明提供了一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法，涉及药物载体技术领域。该核酸疫苗按照摩尔百分比计包括25～75％可质子化阳离子脂质、5～20％阴离子脂质、0～50％结构脂质和1～5％表面活性剂。具有对核酸的包封率高，粒径分布较窄的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN110974954B
Jurisdiction
CN
Classification
—
Expires
2021-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Zhuhai Lifanda Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.